Results 281 to 290 of about 2,610,836 (314)
Some of the next articles are maybe not open access.

Ductal Carcinoma In Situ

Surgical Clinics of North America, 2018
Ductal carcinoma in situ has been stable in incidence for a decade and has an excellent prognosis. Breast conservation therapy is safe and effective for most patients. Adjuvant whole breast radiation therapy is recommended to reduce the risk of local recurrence.
FangMeng Fu   +2 more
  +9 more sources

Is it Time to Retire the Term of Low-Grade Ductal Carcinoma in Situ and Replace it with Ductal Neoplasia?

Advances in Anatomic Pathology, 2023
As the leading cause of cancer morbidity and the second leading cause of cancer mortality among women, breast cancer continues to remain a major global public health problem.
S. Masood, M. Silverstein
semanticscholar   +1 more source

The global existence and numerical method for the free boundary problem of ductal carcinoma in situ

Mathematical methods in the applied sciences, 2022
In this paper, a free boundary problem related to the ductal carcinoma in situ (DCIS) model is under studied. We establish the global existence and uniqueness of the solution for the model with the non‐symmetric free boundaries.
Dan Liu, Keji Liu, Xinyi Xu, Jianfeng Yu
semanticscholar   +1 more source

Carcinoma ductal in situ

EMC - Ginecología-Obstetricia, 2021
Resumen El carcinoma ductal in situ (CDIS) se define como una proliferacion de celulas malignas en los conductos galactoforos, sin que atraviesen la membrana basal. El CDIS representa alrededor el 10-15% del conjunto de los canceres mamarios. Su tratamiento tiene por objetivo prevenir el desarrollo de un cancer infiltrante y, a la vez, evitar un ...
M Lodi   +4 more
openaire   +2 more sources

Updates on treating ductal carcinoma in situ: what's to know in 2021

Current Opinion in Obstetrics and Gynecology, 2021
Supplemental Digital Content is available in the text Purpose of review Ductal carcinoma in situ (DCIS) is a noninvasive stage of disease but understood to be a nonobligate precursor to invasive breast cancer.
F. Haji, Jennifer L. Baker, M. DiNome
semanticscholar   +1 more source

Ductal carcinoma in situ

Surgical Clinics of North America, 2003
DCIS is a heterogeneous disease whose natural history is poorly defined. Screening mammography has increased the detection rate of DCIS, but we remain unable to identify cases of DCIS that will not progress to invasive carcinoma during an individual's lifetime.
Faina Nakhlis, Monica Morrow
openaire   +2 more sources

Ductal Carcinoma In Situ

Human Pathology, 1996
In the past 10 years clinical trials have confirmed the value of breast conserving therapy for invasive breast cancer and many authorities now consider this the preferred and appropriate treatment (NCI Consensus Statement 1992a). However controversy still surrounds the treatment of ductal carcinoma in situ (DCIS).
openaire   +5 more sources

Ductal Carcinoma In Situ

2008
A. Epidemiology and Risk Factors. Ductal carcinoma in situ (DCIS) is a form of noninvasive breast cancer which usually affects women in their sixth decade of life. The disease is characterized by a proliferation of malignant ductal epithelial cells without microscopic invasion through the basement membrane.
Nicola L. P. Barnes, Nigel J. Bundred
openaire   +3 more sources

Ductal Carcinoma in Situ

Surgical Clinics of North America, 2013
Management of ductal carcinoma in situ (DCIS) has evolved from radical surgery to the option of a more minimally invasive approach. Data show that breast conservation surgery performed with administration of radiotherapy, like mastectomy, is feasible and safe.
openaire   +3 more sources

Performance of linear and stochastic cell-growth model of ductal carcinoma in situ (DCIS)

Journal of Advanced Research in Applied Sciences and Engineering Technology
According to World Health Organization (WHO), in 2020 there were 2.3 million of women have been diagnosed with breast cancer and there are up to 685,000 deaths globally.
Nurul Anis Abdul Satar   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy